XML 132 R108.htm IDEA: XBRL DOCUMENT
v3.21.1

Contract Liabilities (Details) - EUR (€) € in Thousands | 3 Months Ended | 12 Months Ended |
--- | --- | --- | ---
Dec. 31, 2019 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2020
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |  |
Shortterm contract liabilities |  |  | € 548 |
Longterm contract liabilities |  |  | 1,673 |
Total contract liabilities |  |  | 2,221 |
Revenue to be recognized |  |  | 7,915 |
Milestone payment |  |  | 0 |
BI |  |  |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |  |
Shortterm contract liabilities |  |  | 436 |
Longterm contract liabilities |  |  | 1,673 |
Total contract liabilities |  |  | 2,109 |
Revenue to be recognized |  |  | 7,718 |
Contract liabilities reversed | € 2,100 | € 2,200 |  |
Milestone payment |  |  | 2,500 |
Milestone payment recognized in revenue |  | € 700 | 200 |
Contract liabilities booked |  |  | 1,800 |
Contract liabilities related to research fees |  |  | 300 |
AbbVie |  |  |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |  |
Shortterm contract liabilities |  |  | 15 |
Total contract liabilities |  |  | 15 |
Revenue to be recognized |  |  | 100 |
Milestone payment |  |  |  | € 0
Contract liabilities related to research fees |  |  | 15 |
EnyoParma |  |  |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |  |  |
Shortterm contract liabilities |  |  | 97 |
Total contract liabilities |  |  | 97 |
Revenue to be recognized |  |  | 97 |
Contract liabilities related to research fees |  |  | € 100 |

X
- Definition The amount of an entity’s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2020-01-01 -Paragraph 105 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_105&doctype=Standard -URIDate 2020-01-01 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2020-01-01 -Paragraph 116 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_116_a&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_ContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current contract liabilities. [Refer: Contract liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2020-01-01 -Paragraph 105 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_105&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_CurrentContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of non-current contract liabilities. [Refer: Contract liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2020-01-01 -Paragraph 105 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2020-en-r&anchor=para_105&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_NoncurrentContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of remaining contract liabilities. + References No definition available. + Details
Name: | iva_CollaborativeArrangementContractLiabilities
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the milestone payments received recognized as revenue. + References No definition available. + Details
Name: | iva_CollaborativeArrangementMilestonePaymentRecognizedInRevenue
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the cumulative amount of research funding received in a collaborative arrangement. + References No definition available. + Details
Name: | iva_CollaborativeArrangementMilestonePaymentsReceived
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the amount of reversal of contract liabilities recognized under IFRS 15. + References No definition available. + Details
Name: | iva_CollaborativeArrangementReversalOfContractLiabilities
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of difference between payment received and revue recognized related to research fees. + References No definition available. + Details
Name: | iva_ContractLiabilitiesResearchFeesReceivable
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of revenue to be recognized. + References No definition available. + Details
Name: | iva_RevenueToBeRecognized
Namespace Prefix: | iva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | iva_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=iva_ResearchAndDevelopmentCollaborationWithBoehringerIngelheimMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | iva_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=iva_ResearchCollaborationWithAbbvieMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | iva_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=iva_ResearchAndDevelopmentCollaborationWithEnyopharmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |